Neurologic Manifestations  >>  dronabinol oral  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dronabinol oral / Generic mfg.
NCT00123201: Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache

Completed
2
US
Dronabinol MDI
Solvay Pharmaceuticals, Nektar Therapeutics
Migraine With Aura, Migraine Without Aura
03/07
03/07
NCT00176163: Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain

Completed
2
240
Europe
Operant behavioral treatment; Drug: THC
Heidelberg University, Central Institute of Mental Health, Mannheim, University of Mannheim, Academic City Hospital, Germany, BG Trauma Center Ludwigshafen
Fibromyalgia, Back Pain
 
05/09
NCT00316563: Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

Completed
2
80
Canada
Marinol (Dronabinol), Placebo
Alberta Health services, University of Alberta
Cancer, Anorexia, Taste Disorders, Olfactory Disorders
 
11/09
NCT01551511 / 2012-000730-19: Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

Completed
2
29
Europe
Tetrahydrocannabinol, Namisol, Dronabinol, Placebo
Radboud University Medical Center, European Union
Pancreatitis, Chronic, Abdominal Pain, Chronic Pain
06/14
06/14
NCT00682929: Cannabis for Spasticity in Multiple Sclerosis

Terminated
1/2
41
US
Inhaled Cannabis, Cannabis, Oral THC, dronabinol, Oral Placebo, placebo, Inhaled placebo
University of California, Davis, National Multiple Sclerosis Society
Multiple Sclerosis
08/11
08/11

Download Options